Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6GC2

AbLIFT: Antibody stability and affinity optimization by computational design of the variable light-heavy chain interface

Summary for 6GC2
Entry DOI10.2210/pdb6gc2/pdb
DescriptorLight Chain, Heavy chain (3 entities in total)
Functional Keywordsantibody, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight51742.77
Authors
Warszawski, S.,Katz, A.,Khmelnitsky, L.,Ben Nissan, G.,Javitt, G.,Dym, O.,Unger, T.,Knop, O.,Diskin, R.,Albeck, S.,Fass, D.,Sharon, M.,Fleishman, S.J. (deposition date: 2018-04-17, release date: 2019-05-01, Last modification date: 2024-10-09)
Primary citationWarszawski, S.,Katz, A.B.,Lipsh, R.,Khmelnitsky, L.,Ben Nissan, G.,Javitt, G.,Dym, O.,Unger, T.,Knop, O.,Albeck, S.,Diskin, R.,Fass, D.,Sharon, M.,Fleishman, S.J.
Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces.
Plos Comput.Biol., 15:e1007207-e1007207, 2019
Cited by
PubMed Abstract: Antibodies developed for research and clinical applications may exhibit suboptimal stability, expressibility, or affinity. Existing optimization strategies focus on surface mutations, whereas natural affinity maturation also introduces mutations in the antibody core, simultaneously improving stability and affinity. To systematically map the mutational tolerance of an antibody variable fragment (Fv), we performed yeast display and applied deep mutational scanning to an anti-lysozyme antibody and found that many of the affinity-enhancing mutations clustered at the variable light-heavy chain interface, within the antibody core. Rosetta design combined enhancing mutations, yielding a variant with tenfold higher affinity and substantially improved stability. To make this approach broadly accessible, we developed AbLIFT, an automated web server that designs multipoint core mutations to improve contacts between specific Fv light and heavy chains (http://AbLIFT.weizmann.ac.il). We applied AbLIFT to two unrelated antibodies targeting the human antigens VEGF and QSOX1. Strikingly, the designs improved stability, affinity, and expression yields. The results provide proof-of-principle for bypassing laborious cycles of antibody engineering through automated computational affinity and stability design.
PubMed: 31442220
DOI: 10.1371/journal.pcbi.1007207
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.55 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon